DE69326351D1 - Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe - Google Patents

Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe

Info

Publication number
DE69326351D1
DE69326351D1 DE69326351T DE69326351T DE69326351D1 DE 69326351 D1 DE69326351 D1 DE 69326351D1 DE 69326351 T DE69326351 T DE 69326351T DE 69326351 T DE69326351 T DE 69326351T DE 69326351 D1 DE69326351 D1 DE 69326351D1
Authority
DE
Germany
Prior art keywords
pct
enzymes
brorelain
treating non
infectious diarrhea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69326351T
Other languages
English (en)
Other versions
DE69326351T2 (de
Inventor
Tracey Leahanne Mynott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213862A external-priority patent/GB9213862D0/en
Priority claimed from GB939308164A external-priority patent/GB9308164D0/en
Priority claimed from GB939313189A external-priority patent/GB9313189D0/en
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Application granted granted Critical
Publication of DE69326351D1 publication Critical patent/DE69326351D1/de
Publication of DE69326351T2 publication Critical patent/DE69326351T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69326351T 1992-06-30 1993-06-30 Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe Expired - Fee Related DE69326351T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929213862A GB9213862D0 (en) 1992-06-30 1992-06-30 Medical use of enzymes
GB939308164A GB9308164D0 (en) 1993-04-20 1993-04-20 Medical use of enzymes
GB939313189A GB9313189D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes
PCT/GB1993/001374 WO1994000147A1 (en) 1992-06-30 1993-06-30 Use of enzymes, especially bromelain, in the treatment of diarrhoea

Publications (2)

Publication Number Publication Date
DE69326351D1 true DE69326351D1 (de) 1999-10-14
DE69326351T2 DE69326351T2 (de) 2000-05-18

Family

ID=27266268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326351T Expired - Fee Related DE69326351T2 (de) 1992-06-30 1993-06-30 Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe

Country Status (14)

Country Link
US (1) US5928640A (de)
EP (1) EP0671943B1 (de)
JP (1) JPH08503691A (de)
AT (1) ATE184200T1 (de)
AU (1) AU672986B2 (de)
CA (1) CA2137674A1 (de)
DE (1) DE69326351T2 (de)
DK (1) DK0671943T3 (de)
ES (1) ES2138625T3 (de)
GR (1) GR3031961T3 (de)
HK (1) HK1004193A1 (de)
NZ (1) NZ253748A (de)
SG (1) SG42846A1 (de)
WO (1) WO1994000147A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes
CN1252101A (zh) 1997-02-25 2000-05-03 科特克斯(英国)有限公司 菠萝蛋白酶成分
WO1998038319A1 (en) * 1997-02-25 1998-09-03 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
DE59805215D1 (de) * 1998-07-15 2002-09-19 Ursapharm Arzneimittel Gmbh Verwendung von bromelainproteasen zur hemmung der blutgerinnung
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
US20040166198A1 (en) * 2001-04-25 2004-08-26 Kiers Jeroen Lucas Process for the manufacture of a fermented health-promoting product
UA91521C2 (ru) * 2004-10-14 2010-08-10 Элтус Фармасьютикалз Инк. Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US8422667B2 (en) 2005-01-27 2013-04-16 The Chamberlain Group, Inc. Method and apparatus to facilitate transmission of an encrypted rolling code
US9148409B2 (en) 2005-06-30 2015-09-29 The Chamberlain Group, Inc. Method and apparatus to facilitate message transmission and reception using different transmission characteristics
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
ES2909565T3 (es) 2016-01-31 2022-05-09 Mediwound Ltd Composición desbridante para el tratamiento de heridas
US10652743B2 (en) 2017-12-21 2020-05-12 The Chamberlain Group, Inc. Security system for a moveable barrier operator
US11074773B1 (en) 2018-06-27 2021-07-27 The Chamberlain Group, Inc. Network-based control of movable barrier operators for autonomous vehicles
WO2020028502A1 (en) 2018-08-01 2020-02-06 The Chamberlain Group, Inc. Movable barrier operator and transmitter pairing over a network
US10997810B2 (en) 2019-05-16 2021-05-04 The Chamberlain Group, Inc. In-vehicle transmitter training

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617417A1 (de) * 1966-12-08 1971-03-25 Ciba Geigy Pharmazeutisches Praeparat
JPS5299207A (en) * 1976-02-16 1977-08-19 Kaken Pharmaceut Co Ltd Remedy for cattle diarrhea
FR2414554A1 (fr) * 1978-01-13 1979-08-10 Steeg Lottie Nouveau milieu de culture bacterienne et ses applications comme additif alimentaire et medicament pour animaux
DE3789965T2 (de) * 1986-08-28 1994-10-13 Enzacor Pty Ltd Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren.
EP0319545B1 (de) * 1986-08-28 1992-03-18 Enzacor Properties Limited Tierwachstumserreger
RU2113220C1 (ru) * 1991-07-24 1998-06-20 Энзакор Пропертиз Лимитед Композиция, способ лечения кишечной инфекции, способ неспецифической стимуляции имvунной системы, способ доставки биологически активного материала в верхние отделы тонкого кишечника
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
ES2138625T3 (es) 2000-01-16
NZ253748A (en) 1997-06-24
US5928640A (en) 1999-07-27
AU4507493A (en) 1994-01-24
AU672986B2 (en) 1996-10-24
DE69326351T2 (de) 2000-05-18
GR3031961T3 (en) 2000-03-31
CA2137674A1 (en) 1994-01-06
ATE184200T1 (de) 1999-09-15
SG42846A1 (en) 1997-10-17
EP0671943A1 (de) 1995-09-20
JPH08503691A (ja) 1996-04-23
HK1004193A1 (en) 1998-11-20
WO1994000147A1 (en) 1994-01-06
EP0671943B1 (de) 1999-09-08
DK0671943T3 (da) 2000-03-27

Similar Documents

Publication Publication Date Title
DE69326351D1 (de) Verwendung von enzymen insbesondere brorelain zur behandlung von nicht-infektiöser diarrhöe
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
ATE202701T1 (de) Behandlung und prophylaxe von durch parasiten oder bakterien verursachten erkrankungen
DE69508192T2 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
ATE169445T1 (de) Verwendung von gelformulierungen als beizmittel
ATE225699T1 (de) Verfahren zur behandlung von holz am glaspunkt
EP0595995A4 (en) Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity
DE69716434D1 (de) Verwendung von lysin zur behandlung des haarausfalls
CA2090138A1 (fr) Procede de traitement de la flore contaminant les circuits papetiers mettant en oeuvre des bacteries
FI961054A (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
ATE141053T1 (de) Verwendung von torasemid zur behandlung von hirnödemen
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE208202T1 (de) Verwendung von dimeticon zur behandlung der konstipation
DE59408087D1 (de) Substituierte heteroarylalkylthiopyridine zur bekämpfung von helicobacter bakterien
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GB9304399D0 (en) Novel process
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
DK0703916T3 (da) 14-Substituerede marcfortiner og derivater, der kan anvendes som antispirant-midler
ATE163344T1 (de) Zusammensetzungen zur behandlung von geernteter pflanzenmaterial
DK0673377T3 (da) Nye triazoloquinazoliner, fremstilling og anvendelse deraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee